Patents by Inventor Michelle Barton

Michelle Barton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND APPARATUS FOR PROVIDING AN ANTIMICROBIAL COVERING FOR WIRELESS ELECTRONIC DEVICES
    Publication number: 20160359514
    Abstract: A cover for a wireless electronic device, comprising a shield forming an envelope defining an interior space configured to receive a wireless electronic device, the shield having at least one opening whereby a wireless electronic device may enter the envelope, the shield being configured to allow a user to operate a wireless electronic device, and the shield comprising an antimicrobial material.
    Type: Application
    Filed: June 2, 2015
    Publication date: December 8, 2016
    Applicant: Clear Image, dba Clear Bags
    Inventors: Kirk Norman, Jarrod Morgan, Michelle Barton
  • P53 MODULATOR AND CANCER TARGET
    Publication number: 20130045214
    Abstract: Methods of screening for modulators of TRIM24 (also known as TIF1-ALPHA) expression and/or biological activity are described. In particular, methods of screening for modulators of TRIM24 E3 ligase activity, and specifically an E3 ligase activity directed at p53 as the target polypeptide are also described. Modulators of TRIM24 expression and activity are provided and their use in treatment of cancer, particularly in breast, colon, prostate, renal cancers and in acute lymphoblastic leukemia. Suitable modulators of TRIM24 expression include siRNA and shRNA and can be used in the treatment of cancer and for targeting cancer stem cells.
    Type: Application
    Filed: June 25, 2012
    Publication date: February 21, 2013
    Inventor: Michelle Barton
  • P53 modulator and cancer target
    Patent number: 8211635
    Abstract: Methods of screening for modulators of TRIM24 (also known as TIF1-ALPHA) expression and/or biological activity are described. In particular, methods of screening of screening for modulators of TRIM24 E3 ligase activity, and specifically an E3 ligase activity directed at p53 as the target polypeptide are also described. Modulators of TRIM24 expression and activity are provided and their use in treatment of cancer, particularly in breast, colon, prostate, renal cancers and in acute lymphoblastic leukaemia. Suitable modulators of TRIM24 expression include siRNA and shRNA and can be used in the treatment of cancer and for targeting cancer stem cells.
    Type: Grant
    Filed: July 3, 2008
    Date of Patent: July 3, 2012
    Assignee: Board of Regents, The University of Texas System
    Inventor: Michelle Barton
  • P53 MODULATOR AND CANCER TARGET
    Publication number: 20100189725
    Abstract: Methods of screening for modulators of TRIM24 (also known as TIF1-ALPHA) expression and/or biological activity are described. In particular, methods of screening of screening for modulators of TRIM24 E3 ligase activity, and specifically an E3 ligase activity directed at p53 as the target polypeptide are also described. Modulators of TRIM24 expression and activity are provided and their use in treatment of cancer, particularly in breast, colon, prostate, renal cancers and in acute lymphoblastic leukaemia. Suitable modulators of TRIM24 expression include siRNA and shRNA and can be used in the treatment of cancer and for targeting cancer stem cells.
    Type: Application
    Filed: July 3, 2008
    Publication date: July 29, 2010
    Inventor: Michelle Barton